Brief: Vericel Q1 EPS USD -0.08
08/05/2024 12:55
May 08 (Reuters) - Vericel Q1 adjusted EBITDA margin 14%. * Q1 gross margin 69% * Q1 net income USD -3.9 million * Q1 adjusted EBITDA USD 7.2 million vs. IBES estimate USD 4.8 million * outlook FY revenue USD 238-242 million
Recent news on Vericel
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
Vericel Corp reports results for the quarter ended June 30 - Earnings Summary
Vericel beats Q2 revenue estimates, boosts annual outlook
Brief: Vericel Q2 EPS USD 0.04
Vericel beats Q1 revenue on MACI, burn care growth, lifts 2026 sales outlook